开瑞龙

Kairuilong (Beijing) Pharmaceutical is an international biotechnology company specializing in the development of advanced nanomedicine and drug delivery systems. The company focuses on translating nanotechnology research into clinical applications, particularly through the development of polymer micelle formulations for oncology. Its lead programs include micelle-based versions of established chemotherapeutic agents like doxorubicin and docetaxel, aimed at improving efficacy and reducing toxicity in the treatment of metastatic breast and gastric cancers. Kairuilong operates with a global perspective, maintaining strategic partnerships with innovation centers in Boston and establishing a significant research and manufacturing presence in Chengdu's Tianfu International Bio-town.